[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555162":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":28,"responsibleParty":44,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":65,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"University Medical Center Goettingen","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Revised Atlanta classifiaction (RAC) I - mild",null,"No local or systemic complication",{"label":13,"type":10,"description":14,"interventionNames":10},"Revised Atlanta classifiaction (RAC) II - moderate severe","Local complications as necrosis or fluid collection or organ failure \\\u003C 48h",{"label":16,"type":10,"description":17,"interventionNames":10},"Revised Atlanta classifiaction (RAC) III - severe","Organ failure \\> 48h",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Christoph Ammer-Herrmenau, Dr","CONTACT","+491704075339","christoph.herrmenau@med.uni-goettingen.de",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Jacob Hamm, Dr","+495513963231","jacob.hamm@med.uni-goettingen.de",[29],{"facility":5,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Göttingen","Lower Saxony","37075","Germany","DE",{"type":37,"coordinates":38},"Point",[39,40],9.93228,51.53443,{"lat":40,"lon":39},[43],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Christoph Ammer-Herrmenau","Dr.","100555162","pancreatitis---microbiome-as-predictor-of-severity-ii-100555162",false,"NCT06508502","Pancreatitis - Microbiome as Predictor of Severity II","P-MAPS II","Inclusion Criteria:\n\n* Patients with initial diagnosis (\\\u003C 48h) of acute pancreatitis\n* Age ≥ 18 years\n* Patients able to understand\u002F give their written consent\n\nExclusion Criteria:\n\n* Recurrent acute pancreatitis (\\>2 previous episodes)\n* Clinical or imaging signs of chronic pancreatitis\n* Referred patients with length of hospital stay \\> 48h","ALL","18 Years",{"count":58,"type":59},700,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the orointestinal microbiome and microbial derived metabolome in patients suffering from acute pancreatitis as a biomarker for severity. The main questions it aims to answer are:\n\n* Can the orointestinal microbiome robustly predict the course of acute pancreatitis?\n* How does the microbiome impact the severity of an acute pancreatitis?\n\nBuccal\u002F rectal swabs, plasma and stool is collected from patients with acute pancreatitis within 48h after hospital admission.",[63,64],"Acute Pancreatitis","Acute Pancreatitis With Infected Necrosis",[66,67],"Pancreatitis","Microbiome","2025-07-10",{"date":70,"type":71},"2025-07-15","ACTUAL",{"date":73,"type":71},"2024-05-01",{"date":75,"type":59},"2027-12-31",{"name":5,"class":6},1]